Tuberculous epididymo-orchitis secondary to Bacillus Calmette-Guérin (BCG) in non-muscular invasive bladder cancer

Intravesical BCG therapy is effective in treating bladder cancer. Tuberculous epididymo-orchitis presents as a rare complication. There are very few cases described in which Mycobacterium Bovis produces epididymo-orchitis by itself.

Detalles Bibliográficos
Autores principales: Lara Moscoloni, Luis Felipe, Santarelli, Maximiliano, Spagnuolo, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995483/
https://www.ncbi.nlm.nih.gov/pubmed/33796443
http://dx.doi.org/10.1016/j.eucr.2021.101629
_version_ 1783669929207136256
author Lara Moscoloni, Luis Felipe
Santarelli, Maximiliano
Spagnuolo, Juan
author_facet Lara Moscoloni, Luis Felipe
Santarelli, Maximiliano
Spagnuolo, Juan
author_sort Lara Moscoloni, Luis Felipe
collection PubMed
description Intravesical BCG therapy is effective in treating bladder cancer. Tuberculous epididymo-orchitis presents as a rare complication. There are very few cases described in which Mycobacterium Bovis produces epididymo-orchitis by itself.
format Online
Article
Text
id pubmed-7995483
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-79954832021-03-31 Tuberculous epididymo-orchitis secondary to Bacillus Calmette-Guérin (BCG) in non-muscular invasive bladder cancer Lara Moscoloni, Luis Felipe Santarelli, Maximiliano Spagnuolo, Juan Urol Case Rep Oncology Intravesical BCG therapy is effective in treating bladder cancer. Tuberculous epididymo-orchitis presents as a rare complication. There are very few cases described in which Mycobacterium Bovis produces epididymo-orchitis by itself. Elsevier 2021-03-04 /pmc/articles/PMC7995483/ /pubmed/33796443 http://dx.doi.org/10.1016/j.eucr.2021.101629 Text en © 2021 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Oncology
Lara Moscoloni, Luis Felipe
Santarelli, Maximiliano
Spagnuolo, Juan
Tuberculous epididymo-orchitis secondary to Bacillus Calmette-Guérin (BCG) in non-muscular invasive bladder cancer
title Tuberculous epididymo-orchitis secondary to Bacillus Calmette-Guérin (BCG) in non-muscular invasive bladder cancer
title_full Tuberculous epididymo-orchitis secondary to Bacillus Calmette-Guérin (BCG) in non-muscular invasive bladder cancer
title_fullStr Tuberculous epididymo-orchitis secondary to Bacillus Calmette-Guérin (BCG) in non-muscular invasive bladder cancer
title_full_unstemmed Tuberculous epididymo-orchitis secondary to Bacillus Calmette-Guérin (BCG) in non-muscular invasive bladder cancer
title_short Tuberculous epididymo-orchitis secondary to Bacillus Calmette-Guérin (BCG) in non-muscular invasive bladder cancer
title_sort tuberculous epididymo-orchitis secondary to bacillus calmette-guérin (bcg) in non-muscular invasive bladder cancer
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995483/
https://www.ncbi.nlm.nih.gov/pubmed/33796443
http://dx.doi.org/10.1016/j.eucr.2021.101629
work_keys_str_mv AT laramoscoloniluisfelipe tuberculousepididymoorchitissecondarytobacilluscalmetteguerinbcginnonmuscularinvasivebladdercancer
AT santarellimaximiliano tuberculousepididymoorchitissecondarytobacilluscalmetteguerinbcginnonmuscularinvasivebladdercancer
AT spagnuolojuan tuberculousepididymoorchitissecondarytobacilluscalmetteguerinbcginnonmuscularinvasivebladdercancer

Ejemplares similares